Charles Schwab Investment Management Inc Caribou Biosciences, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 824,657 shares of CRBU stock, worth $2.38 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
824,657
Previous 807,759
2.09%
Holding current value
$2.38 Million
Previous $4.63 Million
8.43%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CRBU
# of Institutions
158Shares Held
67.4MCall Options Held
111KPut Options Held
105K-
Black Rock Inc. New York, NY7.01MShares$20.2 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA6.48MShares$18.7 Million1.64% of portfolio
-
State Street Corp Boston, MA6.35MShares$18.3 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX5.79MShares$16.7 Million1.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.11MShares$11.8 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $175M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...